Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer
- PMID: 29443673
- DOI: 10.1056/NEJMe1800041
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer
Comment on
-
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Clinical Trial.
Similar articles
-
Edoxaban for Cancer-Associated Venous Thromboembolism.N Engl J Med. 2018 Jul 5;379(1):95-96. doi: 10.1056/NEJMc1806646. N Engl J Med. 2018. PMID: 29972743 No abstract available.
-
Edoxaban: How Does the Newest Agent Fit into the DOAC Landscape?Am J Med. 2017 Aug;130(8):900-906. doi: 10.1016/j.amjmed.2017.02.048. Epub 2017 Apr 6. Am J Med. 2017. PMID: 28390791 Review.
-
Edoxaban: A Novel Factor Xa Inhibitor for the Management of Non-valvular Atrial Fibrillation and Venous Thromboembolism.Cardiol Rev. 2016 Jul-Aug;24(4):205-10. doi: 10.1097/CRD.0000000000000104. Cardiol Rev. 2016. PMID: 26991962 Review.
-
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.Thromb Haemost. 2010 Sep;104(3):642-9. doi: 10.1160/TH10-02-0142. Epub 2010 Jun 29. Thromb Haemost. 2010. PMID: 20589317 Clinical Trial.
-
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.Hosp Pract (1995). 2015;43(5):249-57. doi: 10.1080/21548331.2015.1099412. Epub 2015 Nov 7. Hosp Pract (1995). 2015. PMID: 26549305
Cited by
-
Factor Xa inhibitor for venous thromboembolism management in patient with cancer: a systematic review and meta-analysis.F1000Res. 2021 Dec 8;10:1257. doi: 10.12688/f1000research.73883.1. eCollection 2021. F1000Res. 2021. PMID: 35136585 Free PMC article.
-
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma.Neurosurg Rev. 2022 Feb;45(1):451-457. doi: 10.1007/s10143-021-01539-9. Epub 2021 Apr 26. Neurosurg Rev. 2022. PMID: 33900495 Free PMC article.
-
Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists.Scand J Trauma Resusc Emerg Med. 2019 Apr 23;27(1):48. doi: 10.1186/s13049-019-0625-3. Scand J Trauma Resusc Emerg Med. 2019. PMID: 31014373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources